Patents Assigned to Coyote Pharmaceuticals, Inc.
  • TREATING OSTEOPENIA AND RELATED DISORDERS WITH GERANYLGERANYL ACETONE AND DERIVATIVES THEREOF
    Publication number: 20150258041
    Abstract: Provide herein are methods for treating osteopenia with geranylgeranyl acetone (GGA) and derivatives thereof and compositions useful for the same.
    Type: Application
    Filed: November 12, 2014
    Publication date: September 17, 2015
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: William Boyle, Naoki Nakayama
  • PREPARATION OF GGA AND DERIVATIVES THEREOF AND THEIR CO-CRYSTALLIZATION WITH UREA OR THIOUREA
    Publication number: 20150258039
    Abstract: Provided herein are compositions comprising co-crystals of GGA or a GGA derivative (including salts and tauotomers thereof) with urea or thiourea, and processes related to such co-crystals. Also provided herein are methods, compounds, and compositions related to preparing trans GGA and derivatives thereof, and intermediates thereto.
    Type: Application
    Filed: September 30, 2013
    Publication date: September 17, 2015
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: Abril-Hörpel Obsidiana, William Haag, Ann Pierson
  • Treating neurodegenerative diseases with GGA or a derivative thereof
    Patent number: 9119808
    Abstract: Provided herein are methods for improving negative effects of ALS, AD, or ischemia, the methods comprising administering to a subject in need thereof a therapeutically effective amount of GGA, preferably present in the trans form, or a derivative thereof.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: September 1, 2015
    Assignee: Coyote Pharmaceuticals, Inc.
    Inventor: Hiroaki Serizawa
  • Geranyl geranyl acetone (GGA) derivatives and compositions thereof
    Patent number: 9045403
    Abstract: This invention relates to geranylgeranyl acetone (GGA) derivatives and the use of GGA, its isomers, and GGA derivatives in methods for inhibiting neural death, increasing neural activity, increasing axon growth and cell viability, and increasing the survival rate of subjects administered the GGA or GGA derivatives.
    Type: Grant
    Filed: February 27, 2013
    Date of Patent: June 2, 2015
    Assignee: Coyote Pharmaceuticals, Inc.
    Inventors: Hiroaki Serizawa, Ankush B. Argade, Akash Datwani, Natalie Spencer, Yonghua Pan, Florian Ermini
  • GGA DERIVATIVES
    Publication number: 20150133431
    Abstract: This invention relates to geranylgeranyl acetone (GGA) derivatives, pharmaceutical compositions comprising GGA derivatives and the use of GGA derivatives.
    Type: Application
    Filed: July 10, 2014
    Publication date: May 14, 2015
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventor: Gary C. Look
  • GGA AND GGA DERIVATIVES COMPOSITIONS THEREOF AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING PARALYSIS INCLUDING THEM
    Publication number: 20150025077
    Abstract: This invention relates to geranylgeranyl acetone (GGA) derivatives and the use of GGA, its isomers, and GGA derivatives in methods for inhibiting neural death, increasing neural activity, increasing axon growth and cell viability, and increasing the survival rate of subjects administered the GGA or GGA derivatives.
    Type: Application
    Filed: February 27, 2013
    Publication date: January 22, 2015
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: Hiroaki Serizawa, Ankush B. Argade, Akash Datwani, Natalie Spencer, Yonghua Pan, Florian Ermini
  • Polyisoprenyl derivatives and uses thereof
    Publication number: 20140274967
    Abstract: This invention relates generally to polyisoprenyl phosphonate derivatives pharmaceutical compositions comprising polyisoprenyl phosphonate derivatives, and uses thereof.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: William Boyle, Naoki Nakayama
  • Geranylgeranyl acetone and derivatives thereof for intranasal administration
    Publication number: 20140275281
    Abstract: Provide herein are intranasal compositions which include geranylgeranyl acetone (GGA) and/or derivatives thereof and methods for treating a neural disease, disorder or condition with the same.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: Hiroaki Serizawa, Tilmann M. Brotz
  • GGA AND GGA DERIVATIVES COMPOSITIONS THEREOF AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING PARALYSIS INCLUDING THEM
    Publication number: 20130296323
    Abstract: This invention relates to geranylgeranyl acetone (GGA) derivatives and the use of GGA, its isomers, and GGA derivatives in methods for inhibiting neural death, increasing neural activity, increasing axon growth and cell viability, and increasing the survival rate of subjects administered the GGA or GGA derivatives.
    Type: Application
    Filed: February 27, 2013
    Publication date: November 7, 2013
    Applicant: COYOTE PHARMACEUTICALS, INC.
    Inventors: Hiroaki Serizawa, Ankush B. Argade, Akash Datwani, Natalie Spencer, Yonghua Pan, Florian Ermini
  • GERANYLGERANYLACETONE FORMULATIONS AND RETINAL DELIVERY THEREOF
    Publication number: 20130245126
    Abstract: Provided herein is a pharmaceutical formulation comprising at least one geranylgeranyl acetone in the form of an eye drop. Also provided herein are methods of treating neural diseases or disorders by administering such pharmaceutical formulations.
    Type: Application
    Filed: February 27, 2013
    Publication date: September 19, 2013
    Applicant: Coyote Pharmaceuticals, Inc.
    Inventor: Hiroaki Serizawa